
Aclaris Therapeutics Forms Scientific Advisory Board with Renowned Pulmonology Experts
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced the creation of its new Scientific Advisory Board (SAB), marking a strategic step in advancing its focus on immuno-inflammatory diseases. The …
Aclaris Therapeutics Forms Scientific Advisory Board with Renowned Pulmonology Experts Read More